The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, October 03, 2023
Biomic Sciences is recalling all lots of ION Sinus Support, ION Biome Sinus, and Restore Sinus Spray products because FDA testing found the product to...
read more
Tuesday, October 03, 2023
Hospira, a Pfizer company, is recalling Lot Numbers GJ5007, 42290DK, and GH6567 of 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10mL vial; 1% ...
read more
Thursday, August 31, 2023
Endotoxin testing is a critical step in ensuring the quality and safety of many biopharmaceutical products.
read more
Charles River Laboratories, the South Carolina Department of Natural Resources (SCDNR); Gault Seafood, Marsh Point Farm, and the Southern ...
read more
Thursday, August 17, 2023
Wheeler Bio, a clinical contract development and manufacturing organization (CDMO), announced Marc Helouin is appointed Chief Quality and Regulatory ...
read more
Camber Pharmaceuticals is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the ...
read more
Tuesday, January 10, 2023
Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API...
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a...
read more
Wednesday, December 07, 2022
AbbVie and HotSpot Therapeutics, Inc., announced an exclusive worldwide collaboration and option to license agreement for HotSpot's discovery-stage ...
read more
Thursday, November 17, 2022
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active...
read more
Thursday, November 10, 2022
Celerion is expanding its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the ...
read more
Thursday, October 27, 2022
Landmark Bio™, a collective endeavor launched by leaders from academia, the life sciences industry, and world-renowned research hospitals to ...
read more
Sartorius entered a research partnership with The BASE Facility at The University of Queensland (UQ) to improve the manufacturing process of nucleic ...
read more
Valneva announced that the European Commission (EC) approved an amendment to the Advance Purchase Agreement (APA) signed in November 2021 for Valneva’...
read more
Microbiologics, the foremost provider of biomaterials and contract microbiology research services, is pleased to announce the acquisition of ...
read more